6 studies found for:    Intravenous Immunoglobulin (IVIg) for treatment of Alzheimer’s Disease
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Biological: octagam 10%
2 Completed Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Intravenous Immunoglobulin
3 Recruiting A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: Albumin;   Biological: Immune globulin
4 Completed A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%);   Other: Placebo solution
5 Active, not recruiting Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment
Condition: Mild Cognitive Impairment
Intervention: Drug: NewGam 10% IVIG
6 Terminated Long-Term Study of IGIV, 10% in Alzheimer´s Disease
Condition: Alzheimer´s Disease
Intervention: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%)

Indicates status has not been verified in more than two years